Patient-Specific Dosimetry Using Pretherapy [(124)I]m-iodobenzylguanidine ([(124)I]mIBG) Dynamic PET/CT Imaging Before [(131)I]mIBG Targeted Radionuclide Therapy for Neuroblastoma

PURPOSE: Iodine-131-m-iodobenzylguanidine ([(131)I]mIBG) targeted radionuclide therapy (TRT) is a standard treatment for recurrent or refractory neuroblastoma with response rates of 30–40%. The aim of this study is to demonstrate patient-specific dosimetry using quantitative [(124)I]mIBG PET/CT imag...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Imaging Biol
Autors principals: Huang, Shih-ying, Bolch, Wesley E., Lee, Choonsik, Van Brocklin, Henry F., Pampaloni, Miguel H., Hawkins, Randall A., Sznewajs, Aimee, DuBois, Steven G., Matthay, Katherine K., Seo, Youngho
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4336853/
https://ncbi.nlm.nih.gov/pubmed/25145966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-014-0783-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars